Invention Grant
- Patent Title: Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA)
-
Application No.: US12007387Application Date: 2008-01-09
-
Publication No.: US09012418B2Publication Date: 2015-04-21
- Inventor: Albert Duranton , Christine Collin-Djangone , Francis Pruche , Jean-Thierry Simonnet
- Applicant: Albert Duranton , Christine Collin-Djangone , Francis Pruche , Jean-Thierry Simonnet
- Applicant Address: FR Paris
- Assignee: L'Oreal
- Current Assignee: L'Oreal
- Current Assignee Address: FR Paris
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: FR0206796 20020603
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/02 ; C07H21/04 ; A61K8/60 ; A61K31/7088 ; A61Q7/00 ; A61Q19/00 ; A61Q19/02 ; A61Q19/08

Abstract:
Expression of a messenger RNA which encodes a protein which is expressed by differentiated cells, notably the cells of the skin or appendages thereof, is inhibited by topically administering to said differentiated cells a thus effective amount of at least one double-stranded RNA oligonucleotide, formulated into a topically applicable, physiologically acceptable medium therefor; such regime or regimen is useful for treating a variety of afflictions or conditions, e.g., combating the signs of skin aging, stimulating hair growth or retarding loss thereof, inhibiting cellular proliferation and/or differentiation, etc.
Public/Granted literature
- US20090117063A1 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) Public/Granted day:2009-05-07
Information query